No, I’m correct. Dr. Been and Dr. NP understand that leronlimab doses MAY be needed immediately for COVID19, which I discussed previously. HIV approval is still 6+ months away and will not require doses until approval is given. And even HIV doses may not be needed until 2021 as the product will take time to launch and sell. That goes for any other indication EXCEPT COVID19. So, again, BILLIONS of doses are not needed urgently, no matter how you read into it. There will be doses for those most at risk, those hospitalized with a chance to survive and then any “extra doses” can be given to other patients. The U.S. gets priority and then other countries. Pretty simple. Your focus on supply is not an issue now or if approval is given.